Julia is a Research Director and Therapeutic Area Lead for Oncology at Charles River Laboratories in Freiburg, Germany. She earned her DVM from Freie Universität Berlin and Tierspital Zürich, followed by a PhD and postdoctoral work at the Max Planck Institute focused on immunobiology. Since Charles River’s acquisition of Oncotest in 2015, she has overseen PDX-based oncology drug testing platforms, integrating 3D tumor models, in vivo assays, imaging, omics, and translational biomarker development.